[{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604 921 1810", "fax": "604 921 1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the\nclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams FCPA, M.D.", "age": 69, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2025, "totalPay": 711724, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 51, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 535361, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2025, "totalPay": 447547, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 78, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1946, "fiscalYear": 2025, "totalPay": 241138, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.31, "open": 10.21, "dayLow": 9.54, "dayHigh": 10.31, "regularMarketPreviousClose": 10.31, "regularMarketOpen": 10.21, "regularMarketDayLow": 9.54, "regularMarketDayHigh": 10.31, "payoutRatio": 0.0, "beta": 1.917, "forwardPE": -24.461538, "volume": 53931, "regularMarketVolume": 53931, "averageVolume": 72342, "averageVolume10days": 66310, "averageDailyVolume10Day": 66310, "bid": 9.56, "ask": 9.86, "bidSize": 1, "askSize": 1, "marketCap": 17972464, "fiftyTwoWeekLow": 3.5, "fiftyTwoWeekHigh": 98.2, "allTimeHigh": 1563.518, "allTimeLow": 3.5, "fiftyDayAverage": 11.081, "twoHundredDayAverage": 21.88575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1009994, "profitMargins": 0.0, "floatShares": 1674529, "sharesOutstanding": 1883906, "sharesShort": 123407, "sharesShortPriorMonth": 129157, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0655, "heldPercentInsiders": 0.02338, "heldPercentInstitutions": 0.047519997, "shortRatio": 2.7, "shortPercentOfFloat": 0.0656, "impliedSharesOutstanding": 1883906, "bookValue": 9.491, "priceToBook": 1.0051627, "lastFiscalYearEnd": 1753920000, "nextFiscalYearEnd": 1785456000, "mostRecentQuarter": 1753920000, "netIncomeToCommon": -26311868, "trailingEps": -33.87, "forwardEps": -0.39, "lastSplitFactor": "1:10", "lastSplitDate": 1756080000, "enterpriseToEbitda": -0.037, "52WeekChange": 0.69016397, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 9.54, "targetHighPrice": 150.0, "targetLowPrice": 150.0, "targetMeanPrice": 150.0, "targetMedianPrice": 150.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 17866280, "totalCashPerShare": 9.484, "ebitda": -27098176, "totalDebt": 0, "quickRatio": 4.491, "currentRatio": 5.009, "returnOnAssets": -1.2356, "returnOnEquity": -3.62563, "freeCashflow": -18894308, "operatingCashflow": -28170520, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "corporateActions": [], "postMarketTime": 1765585141, "regularMarketTime": 1765573202, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1331731800000, "postMarketChangePercent": 4.8218036, "postMarketPrice": 10.0, "postMarketChange": 0.46000004, "regularMarketChange": -0.77, "regularMarketDayRange": "9.54 - 10.31", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 72342, "fiftyTwoWeekLowChange": 6.04, "fiftyTwoWeekLowChangePercent": 1.7257143, "fiftyTwoWeekRange": "3.5 - 98.2", "fiftyTwoWeekHighChange": -88.659996, "fiftyTwoWeekHighChangePercent": -0.9028513, "fiftyTwoWeekChangePercent": 69.016396, "dividendDate": 1577923200, "earningsTimestampStart": 1749758400, "earningsTimestampEnd": 1750104000, "isEarningsDateEstimate": true, "exchange": "NCM", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -7.46848, "regularMarketPrice": 9.54, "cryptoTradeable": false, "epsTrailingTwelveMonths": -33.87, "epsForward": -0.39, "fiftyDayAverageChange": -1.5410004, "fiftyDayAverageChangePercent": -0.1390669, "twoHundredDayAverageChange": -12.34575, "twoHundredDayAverageChangePercent": -0.5640999, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "marketState": "CLOSED", "displayName": "BriaCell Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]